{"entity":{"id":"markus-graefen","kind":"person","name":"Markus Graefen","aka":[],"tldr":"Markus Graefen leads the Martini-Klinik, the world's highest-volume prostate surgery centre.","summary":"Markus Graefen is Medical Director of the Martini-Klinik Prostate Cancer Center at Universitätsklinikum Hamburg-Eppendorf, the world's highest-volume prostate surgery centre. His specialisms are prostate cancer surgery, radical prostatectomy and functional outcomes, including robotic and minimally invasive approaches. The Martini-Klinik performs thousands of radical prostatectomies a year and publishes outcome data on continence and potency preservation. His papers include a comparison of adjuvant and early salvage radiotherapy for men at high risk of recurrence after prostatectomy, a JAMA Oncology comparison of surgery and radiotherapy for Gleason score 9-10 prostate cancer, and a European Urology study of persistent PSA after radical prostatectomy. His publications are listed on PubMed.","asOf":"2026-09-08","links":[{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Graefen%20M%5BAuthor%5D%20prostatectomy"}],"tags":[],"related":[],"cancers":["prostate"],"sections":[],"technologies":["robotic-surgery"],"targets":[],"drugs":[],"companies":[],"institutions":["uke-hamburg"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Medical Director, Martini-Klinik Prostate Cancer Center, UKE Hamburg","institutionId":"uke-hamburg","specialisms":["Prostate cancer surgery","Radical prostatectomy","Functional outcomes"],"profiles":[{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Graefen%20M%5BAuthor%5D%20prostatectomy"}],"papers":[{"title":"Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death","journal":"Journal of Clinical Oncology","year":2021,"doi":"10.1200/jco.20.03714"},{"title":"Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality","journal":"JAMA Oncology","year":2019,"doi":"10.1001/jamaoncol.2018.4836"},{"title":"Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes","journal":"European Urology","year":2019,"doi":"10.1016/j.eururo.2019.01.048"}]},"route":"/people/markus-graefen/","neighbours":{"cancer":[{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"technology":[{"id":"robotic-surgery","kind":"technology","name":"Robotic & minimally invasive surgery","route":"/technologies/robotic-surgery/"}],"institution":[{"id":"uke-hamburg","kind":"institution","name":"Universitätsklinikum Hamburg-Eppendorf","route":"/institutions/uke-hamburg/"}]}}